These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 3592453)

  • 1. [Cerebral toxoplasmosis in immunosuppressed patients: diagnosis and treatment].
    Leport C; Vildé JL; Katlama C; Regnier B; Mathéron S; Saimot AG
    Ann Med Interne (Paris); 1987; 138(1):30-3. PubMed ID: 3592453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral toxoplasmosis in patients with AIDS.
    Rossitch E; Carrazana EJ; Samuels MA
    Am Fam Physician; 1990 Mar; 41(3):867-73. PubMed ID: 2407076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Opportunistic Toxoplasma gondii infections].
    Reinert P; Bernaudin F
    Arch Fr Pediatr; 1985 Dec; 42 Suppl 2():949-51. PubMed ID: 3833107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cerebral toxoplasmosis in patients with AIDS].
    Altés J; Salas A; Ricart C; Villalonga C; Riera M; Casquero P
    Arch Neurobiol (Madr); 1989; 52 Suppl 1():121-6. PubMed ID: 2637654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy.
    Leport C; Raffi F; Matheron S; Katlama C; Regnier B; Saimot AG; Marche C; Vedrenne C; Vilde JL
    Am J Med; 1988 Jan; 84(1):94-100. PubMed ID: 3337134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrimethamine-sulfadiazine for treating Pneumocystis carinii pneumonia and toxoplasmosis in AIDS.
    Gilman TM; Boylen CT; Sattler FR
    Clin Pharm; 1989 Feb; 8(2):84, 87. PubMed ID: 2645082
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain lesions in patients with acquired immunodeficiency syndrome.
    Bishburg E; Eng RH; Slim J; Perez G; Johnson E
    Arch Intern Med; 1989 Apr; 149(4):941-3. PubMed ID: 2705847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pulmonary toxoplasmosis in AIDS. Report of 3 cases].
    Knani L; Bouslama K; Varette C; Gonzalez Canali G; Cabane J; Lebas J; Imbert JC
    Ann Med Interne (Paris); 1990; 141(5):469-71. PubMed ID: 2256591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasmosis of the central nervous system in patients with AIDS in Mexico.
    del Rio-Chiriboga C; Orzechowski-Rallo A; Sanchez-Mejorada G
    Arch Med Res; 1997; 28(4):527-30. PubMed ID: 9428578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy of specific chemotherapy in the prevention of recurrences of toxoplasmic chorioretinitis during the 4 years following the treatment].
    Timsit JC; Bloch-Michel E
    J Fr Ophtalmol; 1987; 10(1):15-23. PubMed ID: 3598056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pyrimethamine-sulfadiazine resistant cerebral toxoplasmosis in AIDS].
    Langmann P; Klinker H; Richter E
    Dtsch Med Wochenschr; 1995 May; 120(21):780-1. PubMed ID: 7781508
    [No Abstract]   [Full Text] [Related]  

  • 12. Clindamycin therapy of cerebral toxoplasmosis in an AIDS patient.
    Westblom TU; Belshe RB
    Scand J Infect Dis; 1988; 20(5):561-3. PubMed ID: 3222671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Encephalic toxoplasmosis in patients with the acquired immunodeficiency syndrome. A clinico-radiological study and the therapeutic results in 78 cases].
    González-Clemente JM; Miró JM; Pedrol E; Alvarez R; Gatell JM; Mallolas J; Graus F; Mercader JM; Guelar A; Jiménez de Anta MT
    Med Clin (Barc); 1990 Oct; 95(12):441-6. PubMed ID: 2084411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute pancytopenia induced by pyrimethamine during treatment of cerebral toxoplasmosis associated with AIDS. Role of dihydrofolate reductase inhibitors].
    Boudes P; Zittoun J; Sobel A
    Ann Med Interne (Paris); 1990; 141(2):183-6. PubMed ID: 2353761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ocular toxoplasmosis in AIDS].
    Chakroun M; Meyohas MC; Pelosse B; Zazoun L; Vacherot B; Derouin F; Leport C
    Ann Med Interne (Paris); 1990; 141(5):472-4. PubMed ID: 2256592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of clindamycin in the treatment of central nervous system toxoplasmosis.
    Rolston KV; Hoy J
    Am J Med; 1987 Sep; 83(3):551-4. PubMed ID: 3661590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of conventional treatment with pyrimethamine and sulfadiazine for secondary prophylaxis of cerebral toxoplasmosis in a patient with AIDS.
    Faucher B; Moreau J; Zaegel O; Franck J; Piarroux R
    J Antimicrob Chemother; 2011 Jul; 66(7):1654-6. PubMed ID: 21459896
    [No Abstract]   [Full Text] [Related]  

  • 18. [Empirical anti-toxoplasma therapy in cerebral AIDS and Chagas disease. Presentation of 2 cases, review of the literature and proposal of an algorithm].
    Montero A; Cohen JE; Martínez DP; Giovannoni AG
    Medicina (B Aires); 1998; 58(5 Pt 1):504-6. PubMed ID: 9922485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxoplasmic encephalitis in acquired immunodeficiency syndrome.
    Chaddha DS; Kalra SP; Singh AP; Gupta RM; Sanchetee PC
    J Assoc Physicians India; 1999 Jul; 47(7):680-4. PubMed ID: 10778586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of magnetic resonance in the diagnostic definition of neurotoxoplasmosis and in the assessment of the response to pharmacological treatment].
    Sparacia G; Brancatelli G; Sarno C; De Maria M; Lagalla R; Filosto L
    Radiol Med; 1998; 96(1-2):23-8. PubMed ID: 9819614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.